SCHEMBL4563563

SCHEMBL4563563

O=C(CN1CCN(C2CCCCC2)CC1)c1ccc2c(c1)CCNC2

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 2/20 0.59
HPGD P15428 2/20 0.59
MAPT P10636 1/20 0.59
HSD17B10 Q99714 1/20 0.59
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RGS12 O14924 1/20 0.44
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
ACHE P22303 2/20 0.42
MCHR1 Q99705 2/20 0.42
KDM2B Q8NHM5 2/20 0.42
RECQL P46063 1/20 0.42
SIGMAR1 Q99720 1/20 0.40
ALPL P05186 1/20 0.40
ALPG P10696 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4564094 0.99 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL4570023 0.86 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDCYP2C9ALOX15
SCHEMBL4520601 0.83 L3MBTL1 (0.54) ALDH1A1KDM4E
SCHEMBL4505128 0.82 L3MBTL1 (0.55) ALDH1A1KDM4E
SCHEMBL4428553 0.80 L3MBTL3 (0.52) ALDH1A1KDM4E
SCHEMBL4563662 0.79 ALDH1A1 (0.54) ALDH1A1MAPTHSD17B10MEN1KMT2A
SCHEMBL4438453 0.76 L3MBTL3 (0.51) KDM2B
SCHEMBL4249960 0.73 ASIC3 (0.53) SIGMAR1
Hydrochloric Acid SCHEMBL4251263 0.72 ASIC3 (0.52) SIGMAR1
SCHEMBL12896004 0.71 ASIC3 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125741-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR Janssen Pharmaceutica, N.V. (BE) 2009-12-02 EP claimed
WO-2008109336-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-09-12 WO claimed